[1]Broeder AA, Putte L, Rau R，et al. A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis[J].J Rheumatol,2002,29(11)：2288. [2]Weinblatt ME, Keystone EC, Furst DE, et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate： the ARMADA trial[J].Arthritis Rheum,2003,48(3)：855. [3]Broeder AA, Putte L,Saxnet T,et al. Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis：effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation[J].Ann Rheum Dis,2002,61(4)：311.